Monoclonal antibody X18A4 identifies on oncofetal fibronectin epitope distinct from the FDC-6 binding site
- 31 May 1995
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 172 (5), 1526-1536
- https://doi.org/10.1016/0002-9378(95)90491-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: A caveat for cervicovaginal oncofetal fibronectin testing?American Journal of Obstetrics and Gynecology, 1994
- Fetal fibronectin in patients at increased risk for premature birthAmerican Journal of Obstetrics and Gynecology, 1994
- The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric populationAmerican Journal of Obstetrics and Gynecology, 1993
- Steroid regulation of oncofetal fibronectin expression in human cytotrophoblastsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Oncofetal fibronectin in patients with false labor as a predictor of preterm deliveryAmerican Journal of Obstetrics and Gynecology, 1993
- Fetal Fibronectin in Cervical and Vaginal Secretions as a Predictor of Preterm DeliveryNew England Journal of Medicine, 1991
- Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodiesJournal of Immunological Methods, 1987
- Purification, Characterization, andin vitroDifferentiation of Cytotrophoblasts from Human Term Placentae*Endocrinology, 1986
- [15] High efficiency fusion procedure for producing monoclonal antibodies against weak immunogensMethods in Enzymology, 1986
- Binding of soluble form of fibroblast surface protein, fibronectin, to collagenInternational Journal of Cancer, 1977